TY - JOUR
T1 - Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status
AU - Hanyuda, Akiko
AU - Cao, Yin
AU - Hamada, Tsuyoshi
AU - Nowak, Jonathan A.
AU - Qian, Zhi Rong
AU - Masugi, Yohei
AU - da Silva, Annacarolina
AU - Liu, Li
AU - Kosumi, Keisuke
AU - Soong, Thing Rinda
AU - Jhun, Iny
AU - Wu, Kana
AU - Zhang, Xuehong
AU - Song, Mingyang
AU - Meyerhardt, Jeffrey A.
AU - Chan, Andrew T.
AU - Fuchs, Charles S.
AU - Giovannucci, Edward L.
AU - Ogino, Shuji
AU - Nishihara, Reiko
N1 - Funding Information:
A.T.C. previously served as a consultant for Bayer Healthcare, Pozen Inc, and Pfizer Inc. This study was not funded by Bayer Healthcare, Millennium Pharmaceuticals, or Pfizer Inc. All remaining authors have declared no conflicts of interest.
Funding Information:
This work was supported by US National Institutes of Health (NIH) Grants [UM1 CA186107 and P01 CA87969 to Meir J. Stampfer; P01 CA55075 and UM1 CA167552 to Walter C. Willett; K07 CA190673 to R.N.; R01 CA137178 and K24 DK098311 to A.T.C.; P50 CA127003 to C.S.F.; R01 CA151993 and R35 CA197735 to S.O.], by Nodal Award from the Dana-Farber Harvard Cancer Center (to S.O.); and by grants from the Project P Fund, the Friends of the Dana-Farber Cancer Institute, the Bennett Family Fund and the Entertainment Industry Foundation through National Colorectal Cancer Research Alliance. A.H. was supported by the Japan-United States Educational Exchange Promotion Foundation (Fulbright Foundation), Japan and the U.S. T.H. was supported by a fellowship grant from the Uehara Memorial Foundation and by a grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research. Y.M. was supported by a fellowship grant of the Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research. A.T.C. was a Damon Runyon Clinical Investigator.
Publisher Copyright:
© 2017, Springer Science+Business Media Dordrecht.
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Previous studies suggest that abnormal energy balance status may dysregulate intestinal epithelial homeostasis and promote colorectal carcinogenesis, yet little is known about how host energy balance and obesity influence enterocyte differentiation during carcinogenesis. We hypothesized that the association between high body mass index (BMI) and colorectal carcinoma incidence might differ according to tumor histopathologic differentiation status. Using databases of the Nurses’ Health Study and Health Professionals Follow-up Study, and duplication-method Cox proportional hazards models, we prospectively examined an association between BMI and the incidence of colorectal carcinoma subtypes classified by differentiation features. 120,813 participants were followed for 26 or 32 years and 1528 rectal and colon cancer cases with available tumor pathological data were documented. The association between BMI and colorectal cancer risk significantly differed depending on the presence or absence of poorly-differentiated foci (Pheterogeneity = 0.006). Higher BMI was associated with a higher risk of colorectal carcinoma without poorly-differentiated foci (≥30.0 vs. 18.5–22.4 kg/m2: multivariable-adjusted hazard ratio, 1.87; 95% confidence interval, 1.49–2.34; Ptrend < 0.001), but not with risk of carcinoma with poorly-differentiated foci (Ptrend = 0.56). This differential association appeared to be consistent in strata of tumor microsatellite instability or FASN expression status, although the statistical power was limited. The association between BMI and colorectal carcinoma risk did not significantly differ by overall tumor differentiation, mucinous differentiation, or signet ring cell component (Pheterogeneity > 0.03, with the adjusted α of 0.01). High BMI was associated with risk of colorectal cancer subtype containing no poorly-differentiated focus. Our findings suggest that carcinogenic influence of excess energy balance might be stronger for tumors that retain better intestinal differentiation throughout the tumor areas.
AB - Previous studies suggest that abnormal energy balance status may dysregulate intestinal epithelial homeostasis and promote colorectal carcinogenesis, yet little is known about how host energy balance and obesity influence enterocyte differentiation during carcinogenesis. We hypothesized that the association between high body mass index (BMI) and colorectal carcinoma incidence might differ according to tumor histopathologic differentiation status. Using databases of the Nurses’ Health Study and Health Professionals Follow-up Study, and duplication-method Cox proportional hazards models, we prospectively examined an association between BMI and the incidence of colorectal carcinoma subtypes classified by differentiation features. 120,813 participants were followed for 26 or 32 years and 1528 rectal and colon cancer cases with available tumor pathological data were documented. The association between BMI and colorectal cancer risk significantly differed depending on the presence or absence of poorly-differentiated foci (Pheterogeneity = 0.006). Higher BMI was associated with a higher risk of colorectal carcinoma without poorly-differentiated foci (≥30.0 vs. 18.5–22.4 kg/m2: multivariable-adjusted hazard ratio, 1.87; 95% confidence interval, 1.49–2.34; Ptrend < 0.001), but not with risk of carcinoma with poorly-differentiated foci (Ptrend = 0.56). This differential association appeared to be consistent in strata of tumor microsatellite instability or FASN expression status, although the statistical power was limited. The association between BMI and colorectal carcinoma risk did not significantly differ by overall tumor differentiation, mucinous differentiation, or signet ring cell component (Pheterogeneity > 0.03, with the adjusted α of 0.01). High BMI was associated with risk of colorectal cancer subtype containing no poorly-differentiated focus. Our findings suggest that carcinogenic influence of excess energy balance might be stronger for tumors that retain better intestinal differentiation throughout the tumor areas.
KW - Epigenetics
KW - Glandular epithelium
KW - Metabolism
KW - Molecular pathological epidemiology
KW - Overweight
KW - Stem cell
UR - http://www.scopus.com/inward/record.url?scp=85019197704&partnerID=8YFLogxK
U2 - 10.1007/s10654-017-0254-y
DO - 10.1007/s10654-017-0254-y
M3 - Article
C2 - 28510098
AN - SCOPUS:85019197704
SN - 0393-2990
VL - 32
SP - 393
EP - 407
JO - European Journal of Epidemiology
JF - European Journal of Epidemiology
IS - 5
ER -